These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35587324)

  • 21. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
    Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
    J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress.
    Hermelink K; Voigt V; Kaste J; Neufeld F; Wuerstlein R; Bühner M; Münzel K; Rjosk-Dendorfer D; Grandl S; Braun M; von Koch FE; Härtl K; Hasmüller S; Bauerfeind I; Debus G; Herschbach P; Harbeck N
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25882713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
    Wagner LI; Gray RJ; Sparano JA; Whelan TJ; Garcia SF; Yanez B; Tevaarwerk AJ; Carlos RC; Albain KS; Olson JA; Goetz MP; Pritchard KI; Hayes DF; Geyer CE; Dees EC; McCaskill-Stevens WJ; Minasian LM; Sledge GW; Cella D
    J Clin Oncol; 2020 Jun; 38(17):1875-1886. PubMed ID: 32271671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study.
    Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K
    Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
    Mariani M; Collins MWG
    Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study.
    Chen BT; Ghassaban K; Jin T; Patel SK; Ye N; Sun CL; Kim H; Rockne RC; Mark Haacke E; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
    Magn Reson Imaging; 2018 Dec; 54():218-224. PubMed ID: 30076946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agreement Between the Mini-Cog in the Preoperative Clinic and on the Day of Surgery and Association With Postanesthesia Care Unit Delirium: A Cohort Study of Cognitive Screening in Older Adults.
    Tiwary N; Treggiari MM; Yanez ND; Kirsch JR; Tekkali P; Taylor CC; Schenning KJ
    Anesth Analg; 2021 Apr; 132(4):1112-1119. PubMed ID: 33002933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of quality of life among adults with self-reported cancer related cognitive impairment.
    Maeir T; Nahum M; Makranz C; Tsabari S; Peretz T; Gilboa Y
    Disabil Rehabil; 2023 Mar; 45(6):1056-1062. PubMed ID: 35297702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.
    Patel SK; Wong AL; Wong FL; Breen EC; Hurria A; Smith M; Kinjo C; Paz IB; Kruper L; Somlo G; Mortimer JE; Palomares MR; Irwin MR; Bhatia S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26101331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
    Carroll JE; Nakamura ZM; Small BJ; Zhou X; Cohen HJ; Ahles TA; Ahn J; Bethea TN; Extermann M; Graham D; Isaacs C; Jim HSL; Jacobsen PB; McDonald BC; Patel SK; Rentscher K; Root J; Saykin AJ; Tometich DB; Van Dyk K; Zhai W; Breen EC; Mandelblatt JS
    J Clin Oncol; 2023 Jan; 41(2):295-306. PubMed ID: 36179271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demographically Corrected Normative Z Scores on the Neuropsychological Test Battery in Cognitively Normal Older Chinese Adults.
    Ruan Q; Xiao F; Gong K; Zhang W; Zhang M; Ruan J; Zhang X; Chen Q; Yu Z
    Dement Geriatr Cogn Disord; 2020; 49(4):375-383. PubMed ID: 33176318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive performance in survivors of breast cancer and markers of biological aging.
    Carroll JE; Van Dyk K; Bower JE; Scuric Z; Petersen L; Schiestl R; Irwin MR; Ganz PA
    Cancer; 2019 Jan; 125(2):298-306. PubMed ID: 30474160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study.
    Mandelblatt JS; Zhou X; Small BJ; Ahn J; Zhai W; Ahles T; Extermann M; Graham D; Jacobsen PB; Jim H; McDonald BC; Patel SJ; Root JC; Saykin AJ; Cohen HJ; Carroll JE
    J Natl Cancer Inst; 2021 Aug; 113(8):1053-1064. PubMed ID: 33484565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
    O'Farrell E; Smith A; Collins B
    Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.
    Lyon DE; Cohen R; Chen H; Kelly DL; Starkweather A; Ahn HC; Jackson-Cook CK
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1461-74. PubMed ID: 27102492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults.
    Papaliagkas V; Papantoniou G; Tsolaki M; Moraitou D
    Hell J Nucl Med; 2017; 20 Suppl():58-70. PubMed ID: 29324915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.